|
30.11.2006 |
DA |
Den Europæiske Unions Tidende |
C 291/69 |
Liste over markedsføringstilladelser udstedt af EØS-EFTA-staterne i anden halvdel af 2005
(2006/C 291/20)
Under henvisning til afgørelse truffet af Det Blandede EØS-udvalg nr. 74/1999 af 28. maj 1999 opfordres Det Blandede EØS-udvalg til på sit møde den 2. juni 2006 at notere sig følgende lister over markedsføringstilladelser for medicinske specialiteter udstedt i perioden 1. juni-31. december 2005:
|
Bilag I |
Liste over nye markedsføringstilladelser |
|
Bilag II |
Liste over fornyede markedsføringstilladelser |
|
Bilag III |
Liste over udvidede markedsføringstilladelser |
|
Bilag IV |
Liste over tilbagetrukne markedsføringstilladelser |
|
Bilag V |
Liste over suspenderede markedsføringstilladelser |
BILAG I
1. Nye markedsføringstilladelser:
Følgende markedsføringstilladelser er blevet udstedt i EØS-EFTA-staterne i perioden 1. juni-31. december 2005:
|
EU-nummer |
Produkt |
Land |
Udstedelsesdato |
|
EU/1/00/129/001-003 |
Azopt |
Liechtenstein |
31.7.2005 |
|
EU/1/00/131/001-030 |
PegIntron |
Liechtenstein |
30.9.2005 |
|
EU/1/00/134/008-011 |
Lantus |
Liechtenstein |
30.9.2005 |
|
EU/1/00/135/002 |
DaTSCAN |
Liechtenstein |
30.9.2005 |
|
EU/1/00/142/009-010 |
NovoMix |
Liechtenstein |
30.9.2005 |
|
EU/1/00/142/011-016 |
NovoMix |
Liechtenstein |
30.11.2005 |
|
EU/1/00/142/017-022 |
NovoMix |
Liechtenstein |
30.11.2005 |
|
EU/1/01/198/007-010 |
Glivec |
Liechtenstein |
31.7.2005 |
|
EU/1/02/215/001/NO-010/NO |
Pritor Plus |
Norge |
7.9.2005 |
|
EU/1/02/227/003 |
Neulasta |
Liechtenstein |
30.11.2005 |
|
EU/1/02/228/003 |
Neupopeg |
Liechtenstein |
30.11.2005 |
|
EU/1/03/255/001-003 |
Ventavis |
Liechtenstein |
30.11.2005 |
|
EU/1/03/258/013-014 |
Avandamet |
Liechtenstein |
30.9.2005 |
|
EU/1/03/263/001-003/IS |
Dukoral, vaccinesuspension og brusegranulat til oral opløsning. |
Island |
6.10.2005 |
|
EU/1/03/265/003-004 |
Bonviva |
Liechtenstein |
30.9.2005 |
|
EU/1/03/266/003-004 |
Bondenza |
Liechtenstein |
30.9.2005 |
|
EU/1/03/269/001 |
Faslodex |
Liechtenstein |
30.11.2005 |
|
EU/1/03/270/003 |
Kentera |
Liechtenstein |
31.7.2005 |
|
EU/1/04/276/021-032 |
Abilify |
Liechtenstein |
31.7.2005 |
|
EU/1/04/276/033-035 |
Abilify |
Liechtenstein |
30.11.2005 |
|
EU/1/04/279/030-032 |
Lyrica |
Liechtenstein |
30.9.2005 |
|
EU/1/04/280/007 |
Yentreve |
Liechtenstein |
30.9.2005 |
|
EU/1/04/283/007 |
Ariclaim |
Liechtenstein |
30.9.2005 |
|
EU/1/04/289/002 |
Angiox |
Liechtenstein |
31.7.2005 |
|
EU/1/04/296/005-006 |
Cymbalta |
Liechtenstein |
31.7.2005 |
|
EU/1/04/297/005-006 |
Xeristar |
Liechtenstein |
31.7.2005 |
|
EU/1/05/310/001/NO-005/NO |
Fosavance |
Norge |
6.9.2005 |
|
EU/1/05/310/001-005 |
Fosavance |
Liechtenstein |
30.9.2005 |
|
EU/1/05/310/001-005/IS |
Fosavance tabletter |
Island |
20.9.2005 |
|
EU/1/05/311/001/NO-003/NO |
Tarceva |
Norge |
26.9.2005 |
|
EU/1/05/311/001-003 |
Tarceva |
Liechtenstein |
30.9.2005 |
|
EU/1/05/311/001-003/IS |
Tarceva |
Island |
18.10.2005 |
|
EU/1/05/312/001/IS |
Xyrem |
Island |
18.11.2005 |
|
EU/1/05/312/001/NO |
Xyrem |
Norge |
18.11.2005 |
|
EU/1/05/313/001/NO-009/NO |
Vasovist |
Norge |
14.10.2005 |
|
EU/1/05/313/001-009 |
Vasovist |
Liechtenstein |
30.11.2005 |
|
EU/1/05/313/001-009/IS |
Vasovist |
Island |
2.11.2005 |
|
EU/1/05/314/001 |
Kepivance |
Liechtenstein |
30.11.2005 |
|
EU/1/05/314/001/IS |
Kepivance |
Island |
24.11.2005 |
|
EU/1/05/314/001/NO |
Kepivance |
Norge |
22.11.2005 |
|
EU/1/05/315/001 |
Aptivus |
Liechtenstein |
30.11.2005 |
|
EU/1/05/315/001/IS |
Aptivus |
Island |
25.11.2005 |
|
EU/1/05/315/001/NO |
Aptivus |
Norge |
2.11.2005 |
|
EU/1/05/316/001/NO-014/NO |
Procoralan |
Norge |
10.11.2005 |
|
EU/1/05/316/001-014 |
Procoralan |
Liechtenstein |
30.11.2005 |
|
EU/1/05/316/001-014/IS |
Procoralan |
Island |
24.11.2005 |
|
EU/1/05/317/001/NO-014/NO |
Corlentor |
Norge |
10.11.2005 |
|
EU/1/05/317/001-014 |
Corlentor |
Liechtenstein |
30.11.2005 |
|
EU/1/05/317/001-014/IS |
Corlentor |
Island |
24.11.2005 |
|
EU/1/05/318/001 |
Revatio |
Liechtenstein |
30.11.2005 |
|
EU/1/05/318/001/IS |
Revatio |
Island |
28.11.2005 |
|
EU/1/05/318/001/NO |
Revatio |
Norge |
11.11.2005 |
|
EU/1/05/319/001/NO-002/NO |
Xolair |
Norge |
7.11.2005 |
|
EU/1/05/319/001-002 |
Xolair |
Liechtenstein |
30.11.2005 |
|
EU/1/05/319/001-002/IS |
Xolair |
Island |
25.11.2005 |
|
EU/1/05/320/001 |
Noxafil |
Liechtenstein |
30.11.2005 |
|
EU/1/05/320/001/IS |
Noxafil |
Island |
20.11.2005 |
|
EU/1/05/320/001/NO |
Noxafil |
Norge |
23.11.2005 |
|
EU/1/05/321/001 |
Posaconazole SP |
Liechtenstein |
30.11.2005 |
|
EU/1/05/321/001/IS |
Posaconazole SP |
Island |
24.11.2005 |
|
EU/1/05/321/001/NO |
Posaconazole SP |
Norge |
23.11.2005 |
|
EU/2/01/030/003-004 |
Virbagen Omega |
Liechtenstein |
30.9.2005 |
|
EU/2/04/047/001-002/IS |
Purevax RCPCh Fel V, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/04/048/001-002/IS |
Purevax RCP Fel V, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/04/049/001-002/IS |
Purevax RCCh, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/04/050/001-002/IS |
Purevax RCPCh, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/04/051/001-002/IS |
Purevax RC, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/04/052/001-002/IS |
Purevax RCP, pulver og solvens til injektionsvæske. |
Island |
30.6.2005 |
|
EU/2/05/053/001 |
Naxcel |
Liechtenstein |
31.7.2005 |
|
EU/2/05/053/001/IS |
Naxcel, injektionsvæske |
Island |
9.6.2005 |
|
EU/2/05/053/001/NO |
Naxcel |
Norge |
17.6.2005 |
|
EU/2/05/054/001/NO-017/NO |
Profender |
Norge |
30.8.2005 |
|
EU/2/05/054/001-017 |
Profender |
Liechtenstein |
30.9.2005 |
|
EU/2/05/054/001-017/IS |
Profender spot-on opløsning |
Island |
26.8.2005 |
|
EU/2/05/055/001/NO-002/NO |
Equilis Te |
Norge |
12.8.2005 |
|
EU/2/05/055/001-002 |
Equilis Te |
Liechtenstein |
30.9.2005 |
|
EU/2/05/055/001-002/IS |
Equilis Te, injektionsvæske |
Island |
2.8.2005 |
|
EU/2/05/056/001/NO-002/NO |
Equilis Prequenza |
Norge |
12.8.2005 |
|
EU/2/05/056/001-002 |
Equilis Prequenza |
Liechtenstein |
30.9.2005 |
|
EU/2/05/056/001-002/IS |
Equilis Prequenza, injektionsvæske |
Island |
2.8.2005 |
|
EU/2/05/057/001/NO-002/NO |
Equilis Prequenza Te |
Norge |
12.8.2005 |
|
EU/2/05/057/001-002 |
Equilis Prequenza Te |
Liechtenstein |
30.9.2005 |
|
EU/2/05/057/001-002/IS |
Equilis Prequenza Te, injektionsvæske |
Island |
2.8.2005 |
|
EU/2/97/004/011 |
Metacam |
Liechtenstein |
31.7.2005 |
|
EU/2/97/004/012-013 |
Metacam |
Liechtenstein |
30.9.2005 |
BILAG II
2. Fornyede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet fornyet i EØS-EFTA-staterne i perioden 1. juni-31. december 2005:
|
EU-nummer |
Produkt |
Land |
Fornyelsesdato |
|
EU/1/00/129/001/NO-003/NO |
Azopt |
Norge |
30.6.2005 |
|
EU/1/00/129/001-003/IS |
Azopt, øjendråber, suspension, 1 % |
Island |
30.6.2005 |
|
EU/1/05/131/001/NO-005/NO |
PegIntron |
Norge |
24.6.2005 |
|
EU/1/00/131/001-050/IS |
PegIntron |
Island |
28.6.2005 |
|
EU/1/00/131/031-050 |
PegIntron |
Liechtenstein |
30.9.2005 |
|
EU/1/05/132/001/NO-005/NO |
ViraferonPeg |
Norge |
24.6.2005 |
|
EU/1/00/132/001-050 |
ViraferonPeg |
Liechtenstein |
31.7.2005 |
|
EU/1/00/132/001-050/IS |
ViraferonPeg |
Island |
28.6.2005 |
|
EU/1/00/133/001/NO-008/NO |
Optisulin |
Norge |
27.7.2005 |
|
EU/1/00/133/001-008 |
Optisulin |
Liechtenstein |
30.9.2005 |
|
EU/1/00/133/001-008/IS |
Optisulin |
Island |
29.8.2005 |
|
EU/1/00/134/001/NO-029/NO |
Lantus |
Norge |
27.7.2005 |
|
EU/1/00/134/001-007, 012-029 |
Lantus |
Liechtenstein |
30.9.2005 |
|
EU/1/00/134/001-029/IS |
Lantus |
Island |
29.8.2005 |
|
EU/1/00/135/001 |
DaTSCAN |
Liechtenstein |
30.9.2005 |
|
EU/1/00/135/001/NO-002/NO |
DaTSCAN |
Norge |
20.9.2005 |
|
EU/1/00/135/001-002/IS |
DaTSCAN |
Island |
11.10.2005 |
|
EU/1/00/137/001/NO-012/NO |
Avandia |
Norge |
27.7.2005 |
|
EU/1/00/137/001-012 |
Avandia |
Liechtenstein |
30.9.2005 |
|
EU/1/00/137/001-012/IS |
Avandia |
Island |
16.9.2005 |
|
EU/1/00/140/001 |
Visudyne |
Liechtenstein |
31.7.2005 |
|
EU/1/00/140/001/IS |
Visudyne 15 mg pulver til opløsning til injektionsvæske |
Island |
14.7.2005 |
|
EU/1/00/140/001/NO |
Visudyne |
Norge |
27.7.2005 |
|
EU/1/00/141/001 |
Myocet |
Liechtenstein |
30.9.2005 |
|
EU/1/00/141/001/IS |
Myocet |
Island |
13.10.2005 |
|
EU/1/00/141/001/NO |
Myocet |
Norge |
28.9.2005 |
|
EU/1/00/142/004/NO-005/NO |
NovoMix Penfill |
Norge |
13.10.2005 |
|
EU/1/00/142/004-005 |
NovoMix |
Liechtenstein |
30.9.2005 |
|
EU/1/00/142/004-005/IS |
NovoMix 30 Penfill |
Island |
21.10.2005 |
|
EU/1/00/142/009/NO-010/NO |
NovoMix Flexpen |
Norge |
13.10.2005 |
|
EU/1/00/142/009-010/IS |
NovoMix 30 FlexPen |
Island |
21.10.2005 |
|
EU/1/00/143/001/NO-006/NO |
Kogenate Bayer |
Norge |
7.9.2005 |
|
EU/1/00/143/001-006 |
Kogenate |
Liechtenstein |
30.9.2005 |
|
EU/1/00/143/001-006/IS |
Kogenate Bayer |
Island |
7.10.2005 |
|
EU/1/00/144/001/NO-003/NO |
Helixate NexGen |
Norge |
7.9.2005 |
|
EU/1/00/144/001-003 |
Helixate |
Liechtenstein |
30.9.2005 |
|
EU/1/00/144/001-003/IS |
Helixate NexGen |
Island |
7.10.2005 |
|
EU/1/00/145/001 |
Herceptin |
Liechtenstein |
30.9.2005 |
|
EU/1/00/145/001/IS |
Herceptin |
Island |
28.11.2005 |
|
EU/1/00/145/001/NO |
Herceptin |
Norge |
23.9.2005 |
|
EU/1/00/146/001/NO-029/NO |
Keppra |
Norge |
8.8.2005 |
|
EU/1/00/146/001-029 |
Keppra |
Liechtenstein |
30.9.2005 |
|
EU/1/00/146/001-029/IS |
Keppra |
Island |
12.9.2005 |
|
EU/1/00/148/001/NO-004/NO |
Agenerase |
Norge |
12.12.2005 |
|
EU/1/00/148/001-004 |
Agenerase |
Liechtenstein |
30.11.2005 |
|
EU/1/00/148/001-004/IS |
Agenerase |
Island |
16.12.2005 |
|
EU/1/00/149/001 |
Panretin |
Liechtenstein |
30.11.2005 |
|
EU/1/00/149/001/IS |
Panretin |
Island |
16.12.2005 |
|
EU/1/00/149/001/NO |
Panretin |
Norge |
9.12.2005 |
|
EU/1/00/150/001/NO-015/NO |
Actos |
Norge |
2.11.2005 |
|
EU/1/00/150/001-015 |
Actos |
Liechtenstein |
30.11.2005 |
|
EU/1/00/150/001-015/IS |
Actos |
Island |
11.11.2005 |
|
EU/1/00/151/001/NO-013/NO |
Glustin |
Norge |
2.11.2005 |
|
EU/1/00/151/001-013 |
Glustin |
Liechtenstein |
30.11.2005 |
|
EU/1/00/151/001-013/IS |
Glustin |
Island |
11.11.2005 |
|
EU/1/00/152/001-018 |
Infanrix hexa |
Liechtenstein |
30.11.2005 |
|
EU/1/00/153/001-010 |
Infanrix penta |
Liechtenstein |
30.11.2005 |
|
EU/1/00/153/001-010/IS |
Infanrix penta |
Island |
16.12.2005 |
|
EU/1/00/153/001-010/NO |
Infanrix penta |
Norge |
7.12.2005 |
|
EU/1/00152/001-018/NO |
Infanrix hexa |
Norge |
7.12.2005 |
|
EU/1/95/001/001, 003-005, 009, 012, 021-022, 025-028, 031-035/IS |
Gonal-F |
Island |
15.11.2005 |
|
EU/1/95/001/001/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/003/NO-006/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/009/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/012/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/021/NO-022/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/025/NO-028/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/95/001/031/NO-035/NO |
Gonal-F |
Norge |
11.11.2005 |
|
EU/1/98/093/002 |
Forcaltonin |
Liechtenstein |
31.7.2005 |
|
EU/1/99/127/001/NO-044/NO |
IntronA |
Norge |
20.6.2005 |
|
EU/1/99/127/001-044 |
IntronA |
Liechtenstein |
31.7.2005 |
|
EU/1/99/127/001-044/IS |
IntronA |
Island |
27.6.2005 |
|
EU/1/99/128/001/NO-037/NO |
Viraferon |
Norge |
20.6.2005 |
|
EU/1/99/128/001-037 |
Viraferon |
Liechtenstein |
31.7.2005 |
|
EU/1/99/128/001-037/IS |
Viraferon |
Island |
27.6.2005 |
|
EU/2/00/018/001 |
Incurin |
Liechtenstein |
31.7.2005 |
|
EU/2/00/018/001/NO |
Incurin |
Norge |
16.6.2005 |
|
EU/2/00/022//002b-03a |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/022/001/NO-017/NO |
Ibaflin |
Norge |
31.8.2005 |
|
EU/2/00/022/001-017/IS |
Ibaflin |
Island |
15.7.2005 |
|
EU/2/00/022/001a |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/022/001b-02a |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/022/003b-04a |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/022/004b |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/022/005-017 |
Ibaflin |
Liechtenstein |
30.9.2005 |
|
EU/2/00/024/001/IS |
Pruban |
Island |
16.12.2005 |
|
EU/2/99/016/001/NO-006/NO |
Porcilis Pesti |
Norge |
18.7.2005 |
|
EU/2/99/016/001-006 |
Porcilis Pesti |
Liechtenstein |
31.7.2005 |
|
EU/2/99/016/001-006/IS |
Porcilis Pesti |
Island |
13.7.2005 |
|
EU/2/99/017/001/NO-006/NO |
Ibraxion |
Norge |
2.6.2005 |
BILAG III
3. Udvidede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet udvidet i EØS-EFTA-staterne i perioden 1. juni-31. december 2005:
|
EU-nummer |
Produkt |
Land |
Udvidelsesdato |
|
EU/1/00/142/011/NO-013/NO |
NovoMix Penfill 50 |
Norge |
1.11.2005 |
|
EU/1/00/142/001-013/IS |
NovoMix 50 Penfill injektionsvæske, suspension |
Island |
5.10.2005 |
|
EU/1/00/142/014/NO-016/NO |
NovoMix Flexpen 50 |
Norge |
1.11.2005 |
|
EU/1/00/142/014-016/IS |
NovoMix 50 FlexPen injektionsvæske, suspension |
Island |
5.10.2005 |
|
EU/1/00/142/017/NO-019/NO |
NovoMix Penfill 70 |
Norge |
1.11.2005 |
|
EU/1/00/142/017-019/IS |
NovoMix 70 Penfill injektionsvæske, suspension |
Island |
5.10.2005 |
|
EU/1/00/142/020/NO-022/NO |
NovoMix Flexpen 70 |
Norge |
1.11.2005 |
|
EU/1/00/142/020-022/IS |
NovoMix 70 FlexPen injektionsvæske, suspension |
Island |
5.10.2005 |
|
EU/1/03/265/003/NO-004/NO |
Bonviva, filmovertrukne tabletter |
Norge |
28.9.2005 |
|
EU/1/03/265/003-004/IS |
Bonviva, filmovertrukne tabletter |
Island |
25.10.2005 |
|
EU/1/03/266/003/NO-004/NO |
Bondenza, filmovertrukne tabletter |
Norge |
28.9.2005 |
|
EU/1/03/266/003-004/IS |
Bondenza, filmovertrukne tabletter |
Island |
21.10.2005 |
|
EU/1/04/276/021/NO-023/NO |
Abilify, smeltetabletter 5 mg |
Norge |
18.7.2005 |
|
EU/1/04/276/021-023/IS |
Abilify, smeltetabletter 5 mg |
Island |
14.7.2005 |
|
EU/1/04/276/024/NO-026/NO |
Abilify, smeltetabletter 10 mg |
Norge |
18.7.2005 |
|
EU/1/04/276/024-026/IS |
Abilify, smeltetabletter 10 mg |
Island |
14.7.2005 |
|
EU/1/04/276/027/NO-029/NO |
Abilify, smeltetabletter 15 mg |
Norge |
18.7.2005 |
|
EU/1/04/276/027-029/IS |
Abilify, smeltetabletter 15 mg |
Island |
14.7.2005 |
|
EU/1/04/276/030/NO-032/NO |
Abilify, smeltetabletter 30 mg |
Norge |
18.7.2005 |
|
EU/1/04/276/030-032/IS |
Abilify, smeltetabletter 30 mg |
Island |
14.7.2005 |
|
EU/1/04/276/033/NO-035/NO |
Abilify 1mg/ml, oral opløsning |
Norge |
9.11.2005 |
|
EU/1/04/276/033-035/IS |
Abilify 1 mg/ml, oral opløsning |
Island |
1.12.2005 |
|
EU/1/96/026/002/IS |
Invirase, filmovertrukne tabletter 500 mg |
Island |
19.7.2005 |
|
EU/1/96/026/002/NO |
Invirase |
Norge |
9.6.2005 |
|
EU/2/97/004/012/NO-013/NO |
Metacam, 0,5 mg/ml oral suspension til hunde |
Norge |
5.9.2005 |
|
EU/2/97/004/012-013/IS |
Metacam, 0,5 mg/ml oral suspension til hunde |
Island |
2.9.2005 |
BILAG IV
4. Tilbagetrukne markedsføringstilladelser
Følgende markedsføringstilladelser er blevet trukket tilbage i EØS-EFTA-staterne i perioden 1. juni-31. december 2005:
|
EU-nummer |
Produkt |
Land |
Tilbagetræk-ningsdato |
|
EU/1/00/158/001-034/IS |
Opulis |
Island |
9.9.2005 |
|
EU/1/00/168/001/NO-006/NO |
Tenecteplase |
Norge |
9.8.2005 |
|
EU/1/00/168/001-006 |
Tenecteplase |
Liechtenstein |
30.9.2005 |
|
EU/1/02/208/001-008/IS |
Xapit |
Island |
9.9.2005 |
|
EU/1/02/210/001/NO-008/NO |
Rayzon |
Norge |
22.7.2005 |
|
EU/1/02/210/001-008 |
Rayzon |
Liechtenstein |
31.7.2005 |
|
EU/1/02/210/001-008/IS |
Rayzon |
Island |
5.7.2005 |
|
EU/1/02/242/001-024 |
Valdyn |
Liechtenstein |
30.9.2005 |
|
EU/1/02/242/001-024/IS |
Valdyn, filmovertrukne tabletter |
Island |
5.7.2005 |
|
EU/1/02/244/001/NO-024/NO |
Valdyn |
Norge |
22.7.2005 |
|
EU/1/02/244/001-024/IS |
Valdyn |
Liechtenstein |
31.7.2005 |
|
EU/1/96/009/010/NO-017/NO |
Zerit |
Norge |
30.9.2005 |
|
EU/1/96/009/010-017/IS |
Zerit kapsel, langsom frigivelse |
Island |
29.11.2005 |
|
EU/1/96/023/001 |
Cea-Scan |
Liechtenstein |
30.11.2005 |
|
EU/1/96/023/001/IS |
CEA-Scan |
Island |
9.11.2005 |
|
EU/1/97/048/001-014/IS |
Infanrix HepB, suspension til injektion |
Island |
15.6.2005 |
|
EU/2/00/023/001-003 |
Pulsaflox |
Liechtenstein |
30.11.2005 |
BILAG V
5. Suspenderede markedsføringstilladelser
Følgende markedsføringstilladelser er blevet suspenderet i EØS-EFTA-staterne i perioden 1. juni-31. december 2005:
|
EU-nummer |
Produkt |
Land |
Suspensionsdato |
|
EU/1/00/147/001/NO-012/NO |
Hexavac |
Norge |
17.11.2005 |
|
EU/1/00/147/001-008 |
Hexavac |
Liechtenstein |
30.11.2005 |
|
EU/1/00/147/001-008/IS |
Hexavac |
Island |
17.11.2005 |